Lv4
520 积分 2021-03-12 加入
Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibody
1个月前
已完结
World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas
9个月前
已完结
Neoadjuvant PD-1/PD-L1 axis blockade for patients with head and neck squamous cell carcinoma
9个月前
已完结
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
9个月前
已完结
[Comprehensive management guideline for breast cancer follow-up and healthcare (2022 edition)]
9个月前
已完结
[Guidelines on the management of ascites in cirrhosis (2023 version)]
1年前
已完结
Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer
1年前
已完结
Safety and efficacy of neoadjuvant chemotherapy containing bevacizumab and interval debulking surgery for advanced epithelial ovarian cancer: A feasibility study
1年前
已完结
Atezolizumab plus Bevacizumab as a downstaging therapy for liver transplantation in Hepatocellular carcinoma with portal vein thrombosis: The first report
1年前
已完结
Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group
1年前
已完结
皖公网安备34019202002308
